The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: zoledronic acid     Quarter: 2016Q3

Total Drug/Injury Combinations: 347     Number of Pages: 18

DRUGNAME PT EventCount
ZOLEDRONIC ACID Influenza like illness 5 view events
ZOLEDRONIC ACID Jaundice cholestatic 5 view events
ZOLEDRONIC ACID Mouth swelling 5 view events
ZOLEDRONIC ACID Myalgia 5 view events
ZOLEDRONIC ACID Tooth abscess 5 view events
Zoledronic acid Anaemia 4 view events
ZOLEDRONIC ACID Asthenia 4 view events
Zoledronic acid Atrial fibrillation 4 view events
zoledronic acid Breast cancer metastatic 4 view events
Zoledronic acid Chest discomfort 4 view events
ZOLEDRONIC ACID Chikungunya virus infection 4 view events
ZOLEDRONIC ACID Chronic obstructive pulmonary disease 4 view events
Zoledronic acid Disease progression 4 view events
Zoledronic acid Exposed bone in jaw 4 view events
ZOLEDRONIC ACID Eye pain 4 view events
ZOLEDRONIC ACID Fatigue 4 view events
ZOLEDRONIC ACID Hypersensitivity 4 view events
Zoledronic acid Migraine 4 view events
Zoledronic acid Palpitations 4 view events
ZOLEDRONIC ACID Rash 4 view events

Total Drug/Injury Combinations: 347     Number of Pages: 18

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)